Tumor infiltrating lymphocytes (TILs) as a predictive marker of pathological complete response (pCR) in a diverse patient population with early triple negative breast cancer (TNBC) treated with neoadjuvant real-world KEYNOTE-522 regimen.

Breast Cancer Res Treat · 2026 · PMC13309403 · PMID 42360368

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a trend toward significanceno p-value reported

Although a trend toward significance was observed, the sample was underpowered to detect a definitive association.

also in 3,729 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.